KANJINTI trastuzumab 150 mg powder for injection vial - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
KANJINTI trastuzumab 150 mg powder for injection vial AUST R: 296881Active ingredients:
Trastuzumab
Dosage form:
Injection, powder for
Sponsor:
Amgen Australia Pty Ltd
Phone:
1800 803 638
|
Deletion from market:
01 Jan 2026
|
Shortage status:
Discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
Alternative brands are available.
|